Intermolecular, Inc.
IMI
IMI was delisted on the 19th of September, 2019.
34 hedge funds and large institutions have $28.2M invested in Intermolecular, Inc. in 2016 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 8 closing their positions.
0.16% less ownership
Funds ownership: 38.69% → 38.53% (-0.16%)
6% less funds holding
Funds holding: 36 → 34 (-2)
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
19% less capital inflows, than outflows
Capital inflows: $901K | Capital outflows: $1.12M
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$182K |
| 2 |
Renaissance Technologies
New York
|
+$148K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$123K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$90.6K |
| 5 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
+$89.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CPA
Cowen Prime Advisors
New York
|
-$290K |
| 2 |
ERSOT
Employees Retirement System of Texas
Austin,
Texas
|
-$221K |
| 3 |
RA
Royce & Associates
New York
|
-$210K |
| 4 |
6CM
683 Capital Management
New York
|
-$152K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$95.6K |
IMI Hedge Fund Activity: Q2 2016 in Review
34 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Intermolecular, Inc. (IMI) for Q2 2016, worth a combined $28.2M — down 42% from $48.5M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of IMI and 6 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 9 added.
The largest buyer was Jacobs Levy Equity Management, opening a new position worth an estimated $182K. The largest seller was Cowen Prime Advisors, cutting an estimated $290K.
- 34 institutional investors held Intermolecular, Inc. (IMI) as of Q2 2016, down from 36 in Q1 2016.
- Funds reported $28.2M of Intermolecular, Inc. stock for Q2 2016, down 42% quarter-over-quarter.
- 6 funds opened new Intermolecular, Inc. positions in Q2 2016 and 8 closed out, a net change of -2 holders.
- The largest Intermolecular, Inc. buyer in Q2 2016 was Jacobs Levy Equity Management, an estimated $182K added.
- The largest Intermolecular, Inc. seller in Q2 2016 was Cowen Prime Advisors, an estimated $290K sold.
Based on aggregated 13F filings for Q2 2016.